Lower-serum and efficient culture medium of mycoplasma ovipneumoniae and preparation method of lower-serum and efficient culture medium

A technology of Mycoplasma pneumoniae and culture medium, which is applied in the directions of microorganism-based methods, biochemical equipment and methods, and medical preparations containing active ingredients, etc. problems, to achieve the effect of promoting microbial metabolism, inhibiting the growth of miscellaneous bacteria, and promoting protein synthesis

Active Publication Date: 2017-05-10
LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are problems such as long culture time, low titer of live bacteria and poor reproductive ability in culturing Mycoplasma pneumoniae in the culture medium of the prior art
In addition, the serum content in the culture medium of the prior art is generally 20%. Vaccines prepared with high serum content will undoubtedly increase the allergic stress response of the heterologous serum to the sheep body, which will e

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lower-serum and efficient culture medium of mycoplasma ovipneumoniae and preparation method of lower-serum and efficient culture medium
  • Lower-serum and efficient culture medium of mycoplasma ovipneumoniae and preparation method of lower-serum and efficient culture medium

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] 1, the preparation of culture medium of the present invention:

[0052] Basal medium:

[0053] (1) MEM 6.5g

[0054] (2) Sodium pyruvate 6.0 g

[0055] (3) Glucose 6.0 g

[0056] (4) 2.5 ml of phenol red with a mass concentration of 1%

[0057] (5) Hank's solution 500 ml

[0058] (6) 300 ml of deionized water.

[0059] Auxiliary medium:

[0060] (7) 30 ml of fresh yeast extract with a mass concentration of 25%

[0061] (8) 16 ml of L-glutamine with a mass concentration of 3%

[0062] (9) 5.0 ml of L-cysteine ​​with a mass concentration of 10%

[0063] (10) The mass concentration is 15% hydrolyzed milk protein 32.5 ml

[0064] (11) Transferrin (10 mg / ml) 1.0 ml

[0065] (12) Insulin (10 mg / ml) 1.0 ml

[0066] (13) Calf thymus DNA (2mg / ml) 10.0 ml

[0067] (14) Penicillin (200,000 IU / ml) 0.25 ml

[0068] (15) Sterile horse serum 50 ml

[0069] Dissolve the ingredients (1)-(5) in the basal medium into 300ml deionized water (6) one by one, and autoclave at 115...

Embodiment 2

[0071] The preparation of substratum of the present invention:

[0072] Basal medium:

[0073] (1) MEM 6.0g

[0074] (2) Sodium pyruvate 6.0 g

[0075] (3) Glucose 6.0 g

[0076] (4) 2.5 ml of phenol red with a mass concentration of 1%

[0077] (5) Hank's solution 500 ml

[0078] (6) 300 ml of deionized water.

[0079] Auxiliary medium:

[0080] (7) 35 ml of fresh yeast extract with a mass concentration of 25%

[0081] (8) 17 ml of L-glutamine with a mass concentration of 3%

[0082] (9) 5.0 ml of L-cysteine ​​with a mass concentration of 10%

[0083] (10) 35.0 ml of hydrolyzed milk protein with a mass concentration of 15%

[0084] (11) Transferrin (10 mg / ml) 1.0 ml

[0085] (12) Insulin (10 mg / ml) 0.8 ml

[0086] (13) Calf thymus DNA (2mg / ml) 10.0 ml

[0087] (14) Penicillin (200,000 IU / ml) 0.25 ml

[0088] (15) Sterile horse serum 50 ml

[0089] Dissolve the ingredients (1)-(5) in the basal medium into 300ml deionized water (6) one by one, and autoclave at 115°...

Embodiment 3

[0091] Application culture medium of the present invention, improved KM2 medium, improved Thiaucourt's medium, TSB-1 medium carry out comparative test to ovine Mycoplasma pneumoniae Y98 strain:

[0092] 1, the preparation of culture medium of the present invention

[0093] Base fluid:

[0094] (1) MEM 6.0g

[0095] (2) Sodium pyruvate 5.0 g

[0096] (3) Glucose 6.0 g

[0097] (4) 2.5 ml of phenol red with a mass concentration of 1%

[0098] (5) Hank's solution 500 ml

[0099] (6) 300 ml of deionized water.

[0100] Auxiliary medium:

[0101] (7) 30 ml of fresh yeast extract with a mass concentration of 25%

[0102] (8) 16.7 ml of L-glutamine with a mass concentration of 3%

[0103] (9) 5.0 ml of L-cysteine ​​with a mass concentration of 10%

[0104] (10) 33.4 ml of hydrolyzed milk protein with a mass concentration of 15%

[0105] (11) Transferrin (10 mg / ml) 1.0 ml

[0106] (12) Insulin (10 mg / ml) 1.0 ml

[0107] (13) Calf thymus DNA (2mg / ml) 10.0 ml

[0108] (14) ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a lower-serum and efficient culture medium of mycoplasma ovipneumoniae. The lower-serum and efficient culture medium is prepared from the following components: MEM, sodium pyruvate, glucose, Hank's liquid, fresh yeast leaching liquid, L-glutamine, L-cysteine, lactalbumin hydrolysate, calf thymus DNA (Deoxyribonucleic Acid), insulin, transferrin, penicillin, horse serum, phenol red and de-ionized water; the invention provides a preparation method of the lower-serum and efficient culture medium. The lower-serum and efficient culture medium of the mycoplasma ovipneumoniae, disclosed by the invention, has the beneficial effects that the content of the serum is only 5 percent and is 1/4 of the content of the serum in a culture medium in the prior art; the titer of mycoplasma ovipneumoniae semi-finished-product bacterium liquid prepared by the method reaches 10<10>CCU/ml and is obviously higher than that of the culture medium in the prior art. According to the lower-serum and efficient culture medium of the mycoplasma ovipneumoniae, disclosed by the invention, the sensitive stress response to a goat body, caused by heterologous serum, is alleviated, and the biosafety is improved; the titer of bacterium liquid of living bacteria is also improved and the production cost is reduced.

Description

technical field [0001] The invention relates to the technical field of veterinary preparations, in particular to a low-serum high-efficiency medium for Mycoplasma pneumoniae ovis and a preparation method thereof. Background technique [0002] Mycoplasma ovipneumoniae (Mo) can cause interstitial pneumonia in sheep and goats. The clinical features are cough, wheezing, runny nose, emaciation, anemia, and growth retardation. In 1963, Mackay et al first isolated Mycoplasma ovis pneumoniae from the diseased lung of Scottish sheep. Mycoplasma ovis pneumoniae mainly infects sheep and goats. At present, there are reports of the incidence of sheep and goats caused by Mycoplasma ovis pneumoniae in many countries around the world, causing huge economic losses to the world sheep industry. In 1978, Chinese scholars isolated Mycoplasma ovis pneumoniae for the first time in Sichuan Province from offspring lambs of Leicester sheep introduced from New Zealand. Subsequently, many provinces a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N1/20A61K39/02A61P31/04A61P11/00C12R1/35
CPCA61K39/0241C12N1/20
Inventor 陈胜利储岳峰郝华芳赵萍刘永生
Owner LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products